Skip to NavigationSkip to content


Schering-Plough has issued its third earnings warning this year as it continues to suffer under an onslaught from generic competition.
Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut prescription drug costs for patients and health...
AstraZeneca made significant stock market gains following indications its new superstatin Crestor will receive a positive review from US regulatory...
Elan is taking legal action to force King Pharmaceuticals to buy two drugs it urgently needs to divest to help tackle debts of $1.3 billion.
New measures by the FDA to speed up patient access to generic medicines have claimed their first scalp after GlaxoSmithKline withdrew three patents...
UK cell therapy company CellFactors has made progress in its fundraising efforts as it seeks to secure a short-term revenue stream.
British Biotech and Vernalis are to merge, marking a continuation of much-needed consolidation with the UK biotech sector.
A consultant surgeon at Halton Hospital in Cheshire has been elected as new Chairman of the BMA to replace Dr Ian Bogle.
The MHRA has come under criticism from MPs over its efforts to communicate with the public and lead improvements in medicines safety.
Schering-Plough has changed the labelling of its new cholesterol absorbing drug Zetia after some patients reported experiencing hypersensitivity...
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches